News | June 07, 2010
June 7, 2010 – St. Jude Medical and two hospitals agreed to pay $3.7 million to resolve allegations it paid illegal kickbacks to two hospitals to secure heart-device business, the Justice Department (DOJ) said. The government alleges the kickbacks caused false claims to be submitted to federal health care programs in violation of the False Claims Act.
The DOJ said kickbacks included alleged rebates that were retroactive and paid based on a hospital's previous purchases of St. Jude heart-device equipment. The DOJ also said St. Jude paid rebates for purchases of heart-device equipment sold by its competitors to induce purchases of similar equipment from St. Jude in the future.
St. Jude Medical said in a statement the agreement fully resolves the investigation. The company said the allegations centered on small, isolated product rebates that the company paid more than five years ago. St. Jude said it entered into a settlement agreement in order to avoid the potential costs and risks associated with litigation, but does not admit liability or wrongdoing.
Under the terms of the settlement, the company will pay $3.7 million. Parma Community General Hospital, located in Parma, Ohio, is paying $40,000, and Norton Healthcare in Louisville, Ky., is paying $133,300. The government asserted that Parma and Norton were recipients of the improper rebates from St. Jude.
"Hospitals should base their purchasing decisions on what is in the best interests of their patients," said Tony West, assistant attorney general for the civil division of the DOJ. "We will act aggressively to ensure that choices about health care are not tainted by illegal kickbacks."
This action was initiated by the filing of an action under the False Claims Act by an internal whistleblower, Jerry Hudson. Under the qui tam, or whistleblower, provisions of the act, private citizens may bring lawsuits on behalf of the United States and share in any recovery. Hudson's share of the settlement is $640,050.
"St. Jude's marketing strategy interfered with the doctors' independent decision making,” said Warner Mendenhall, Hudson’s attorney from McLaughlin and McCaffrey LLP. “These types of incentives to gain market share shortchange patient care options for doctors and patients alike. These incentives have more to do with sales than patient well-being."
The Complaint can be found at http://www.docstoc.com/docs/39559633/US-ex-rel-Hudson-v-St-Jude-Medical.
For more information: www.sjm.com, www.justice.gov/opa/pr/2010/June/10-civ-658.html
Related Content
News | Cath Lab
MMRI Publishes Breakthrough Study Detailing a Novel Approach to Minimize Damage After a Heart Attack
December 20, 2023 — Jason R. McCarthy, Ph.D., associate professor of biomedical research and translational medicine and ...
December 20, 2023
News | Cath Lab
iFR and FFR are Equally Safe to Diagnose and Treat Heart Disease According to Largest-ever Analysis of New Real-world, Long-term Data
October 26, 2023 — Royal Philips, a global leader in health technology, announced the latest results demonstrating the ...
October 26, 2023
News | Cath Lab
New Shockwave Coronary IVL Publications Confirm Safety and Efficacy Across Multiple Calcium Morphologies
October 25, 2023 — Shockwave Medical, Inc., a pioneer in the development and commercialization of transformational ...
October 25, 2023
News | Cath Lab
Philips Showcases Latest Medical Innovations and Solutions for Patients with Cardiovascular Disease TCT23
October 20, 2023 — Over the coming days, Philips will be presenting its latest solutions in cardiology and new late ...
October 20, 2023
News | Cath Lab
GE HealthCare Receives FDA Clearance of Allia IGS Pulse - the Next Generation of Image-Guided Systems Designed for Cardiac Imaging Excellence
October 16, 2023 — GE HealthCare (Nasdaq: GEHC) announced US FDA 510(k) clearance of Allia IGS Pulse - the latest ...
October 16, 2023
News | Cath Lab
Shimadzu Medical Systems USA Installs First Trinias Score Opera Cardiac Catheterization Lab in the US
October 16, 2023 — Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation, announced the first U.S ...
October 16, 2023
News | Cath Lab
New Study Confirms HeartFlow FFRCT Leads to Improved Patient Outcomes
September 13, 2023 — A diagnostic test, first offered in the United States at University Hospitals (UH) Harrington Heart ...
September 13, 2023
News | Cath Lab
Teleflex Receives FDA Clearance for Expanded Indication for QuikClot Control+ Hemostatic Device Usage in Cardiac Surgical Procedures
August 2, 2023 — Teleflex Incorporated, a leading global provider of medical technologies, announced the U.S Food and ...
August 02, 2023
News | Cath Lab
Mount Sinai Queens Opens New Cardiac Catheterization Lab to Expedite Care for Heart Attack Patients
July 13, 2023 — Mount Sinai Queens announced the opening of a new cardiac catheterization lab that will provide rapid ...
July 13, 2023
News | Cath Lab
Philips and BIOTRONIK Expand Care for Out-of-hospital Cardiology Labs with New Strategic Alliance
June 21, 2023 — Royal Philips, a global leader in health technology, announced it has teamed up with BIOTRONIK (Lake ...
June 21, 2023